FLUOROURACIL ACCORD, FLUOROURACIL INTAS (Accord Healthcare Pty Ltd)
Product name
FLUOROURACIL ACCORD, FLUOROURACIL INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
253 working days (255)
Active ingredients
Fluorouracil
Registration type
New generic medicine
Indication
FLUOROURACIL ACCORD, FLUOROURACIL INTAS (injection), alone or in combination, is indicated for the treatment for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.